Lower hotel occupancy tests balance sheets against the investment load
CBS data for January-May points to lower hotel nights and occupancy, while tourists remain a small share of nights. The effect is not uniform: Isrotel relies more on strong domestic demand, Fattal is more geographically diversified, and Israel Canada Hotels has to fund acquisitions in a weaker revenue environment.
CBS data for January-May point to a hotel market that has not returned to normal: about 6.6 million hotel nights versus about 7.8 million in the comparable period, room occupancy of about 43% versus about 51%, and tourists still representing a small share of nights. That is a negative macro headline, but it does not affect all listed companies the same way. Isrotel reports that strong Israeli demand, especially in the south and luxury/exclusive hotels, offsets weak inbound tourism in most hotels. Fattal is much more geographically diversified, with hundreds of hotels in Israel, Europe and the Mediterranean basin, so Israel is only part of the picture. Israel Canada Hotels is in an acquisition and expansion phase, so weaker demand meets a funding test. Dan Hotels and Issta add different exposures through hotels, tourism and real estate. The question is therefore not whether hotel nights declined, but who can absorb a weaker period without damaging the investment plan and balance sheet.
The macro signal is pressure, not a uniform answer
The central data point is lower nights and lower occupancy. When occupancy falls, the hit is not only to revenue. Hotels carry meaningful fixed costs: payroll, maintenance, rent, energy, booking systems and management. A decline in occupancy can therefore reach operating profit quickly, especially for companies with debt, leases or newly opened hotels that have not yet reached full productivity.
But company exposure differs. An asset owner, a hotel lessee, a third-party manager and a travel-agency operator do not react the same way. The Israel versus Europe mix also changes the read.
| Company | Main exposure | What to check |
|---|---|---|
| Fattal | Broad Israel, Europe and Mediterranean platform | Debt to EBITDA, 2026 guidance and funding capacity |
| Isrotel | Israeli hotels with strong domestic demand | Whether local demand keeps offsetting weak inbound tourism |
| Dan Hotels | Israeli hotels plus real-estate activity | Operating cash flow and balance-sheet resilience |
| Israel Canada Hotels | Expanding hotel platform and acquisitions | Ability to absorb acquisitions during weak demand |
| Issta | Tourism, hotels and real estate | Cash flow, supplier advances and short-term debt |
Isrotel shows the domestic-demand defense
In its first-quarter report, Isrotel said Operation Lion's Roar led to airspace closure, cancellations and lower hotel occupancy. The company estimated lost operating profit in the quarter at about NIS 30 million, mainly because March is usually the strongest month in the quarter.
At the same time, Isrotel said Israeli demand for its hotels remains very high, especially exclusive hotels and hotels in southern Israel, and that the absence of inbound tourism does not materially hurt most of its activity because domestic tourism compensates. That positions Isrotel as more capable of absorbing weak inbound tourism as long as local demand remains strong.
Fattal has diversification, but also leverage
Fattal is a different company. At the end of March it operated or held 315 hotels, 276 of them active, with about 55 thousand rooms; near the report date that had already increased to 318 hotels and about 56 thousand rooms. This diversification reduces dependence on Israel, but increases financing and management complexity.
In the first quarter, Fattal reported revenue of about NIS 1.454 billion, EBITDAR of about NIS 271 million, debt to EBITDA of 4.96, and cash and securities of about NIS 883 million. Its 2026 guidance includes revenue of NIS 8.0-8.4 billion, EBITDAR of NIS 2.8-3.1 billion, EBITDA of NIS 1.5-1.8 billion and FFO of NIS 900 million to NIS 1.1 billion.
For Fattal, the Israeli macro data matter but are not enough. The question is whether European diversification and full-year guidance offset local weakness, and whether leverage stays manageable if some tourism markets remain soft.
Israel Canada Hotels is in acquisition mode
Israel Canada Hotels has a different sensitivity. In the first quarter it reported about NIS 50 million of revenue, a balance sheet of about NIS 2.2 billion, and cash plus short-term deposits of about NIS 187 million near publication. It also raised about NIS 150 million through its first bond issuance and about NIS 70 million through a private placement to Harel.
At the same time, the company expanded through Kfar Giladi and Galilion, Midtown Jerusalem and then the Germany transactions. Weak hotel nights are therefore not only a short-term revenue question. They are a funding and timing question. A company expanding during weak demand has to prove that its balance sheet can support both acquisitions and the recovery period.
Where the separation line runs
The CBS macro data matter because they show that inbound tourism has not normalized. But hotel investing cannot stop there. Investors need to separate companies with strong domestic demand, companies with geographic diversification, companies with heavy acquisitions and companies more exposed to advances, short-term debt or outbound tourism.
In the coming quarters, the right measurement is not only occupancy. Investors should watch RevPAR if disclosed, room revenue, operating cash flow, debt service, leases, CAPEX, acquisitions and hotel-opening timing. Companies with stronger balance sheets can wait for tourists. Companies expanding fast need to prove they are not buying rooms faster than they can finance them.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.